Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.49 |
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 6/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | CRHBP | P24387 | 1/20 | 0.44 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 2/20 | 0.39 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1255707 | 0.94 | TDP1 (0.50) | TDP1MEN1KMT2AL3MBTL1MAPK1 | |
| SCHEMBL11655565 | 0.89 | TDP1 (0.56) | TDP1MEN1KMT2AL3MBTL1MAPK1 | |
| SCHEMBL21073906 | 0.87 | TDP1 (0.55) | TDP1MEN1KMT2AL3MBTL1MAPK1 | |
| SCHEMBL6901399 | 0.87 | TDP1 (0.55) | TDP1MEN1KMT2AL3MBTL1MAPK1 | |
| SCHEMBL168673 | 0.85 | TDP1 (0.44) | TDP1MEN1KMT2AL3MBTL1MAPK1 | |
| SCHEMBL7659602 | 0.84 | TDP1 (0.56) | TDP1MEN1KMT2AL3MBTL1MAPK1 | |
| SCHEMBL4416132 | 0.83 | TDP1 (0.51) | TDP1MEN1KMT2AL3MBTL1MAPK1 | |
| SCHEMBL10017368 | 0.81 | TDP1 (0.50) | TDP1MEN1KMT2AL3MBTL1MAPK1 | |
| SCHEMBL168051 | 0.81 | ZDHHC7 (0.41) | TDP1MEN1KMT2AL3MBTL1MAPK1 | |
| SCHEMBL2948251 | 0.81 | TDP1 (0.50) | TDP1MEN1KMT2AL3MBTL1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101302145-B | Stilbene derivatives, liquid crystal mixture and electrooptical display | MERCK PATENT GMBH | 2015-07-22 | — | — | CN | disclosed |
| EP-1932896-B1 | Stilbene derivatives, liquid-crystal mixtures and electro-optical displays | MERCK PATENT GMBH (DE) | 2010-10-27 | — | — | EP | disclosed |
| US-7732022-B2 | Stilbene derivatives, liquid-crystal mixtures and electro-optical displays | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2010-06-08 | — | — | US | disclosed |
| US-20080149891-A1 | STILBENE DERIVATIVES, LIQUID-CRYSTAL MIXTURES AND ELECTRO-OPTICAL DISPLAYS | MERCK PATENT GESELLSCHAFT (DE) | 2008-06-26 | — | — | US | disclosed |
| EP-1932896-A1 | Stilbene derivatives, liquid-crystal mixtures and electro-optical displays | MERCK PATENT GmbH (DE) | 2008-06-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080149891-A1 | STILBENE DERIVATIVES, LIQUID-CRYSTAL MIXTURES AND ELECTRO-OPTICAL DISPLAYS | SBDS, LSS, VCL | TDP1 2240/4885MEN1 2434/4885KMT2A 4401/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.